fbpx

Ep.251: Yuval Landschaft, Israeli Medical Cannabis Agency

Cannabis Economy Podcast
Ep.251: Yuval Landschaft, Israeli Medical Cannabis Agency

Ep.251: Yuval Landschaft, Israeli Medical Cannabis Agency

The Director of the Isreali Medical Cannabis Agency, Yuval Landschaft joins us to take us through cannabis regulations in the holy land. Not originally a cannabis enthusiast, Yuval  eventually understood where we were with it’s potential – as standing on the shore of an island. Years later, after deepening his understanding of the agricultural, manufacturing, medical and otherwise…that we’re standing at the shore of a continent. He contends that maybe the ancients knew something that we’re now trying to discover again. Israel is in the process of medicalization at Yuval puts it ensuring that each patient ties an indication or qualifying condition to his or her cannabis use. From there, the country has five books worth of information on how the program works- which Yuval takes us through.

Transcript:

Speaker 1: When there's doubt, take the high road for more. Go to [inaudible] dot com slash Canada economy, vall land shaft, the director of the Israeli medical cannabis agency. You've all land chef joins us to take us through cannabis regulations in the Holy Land, not originally a cannabis enthusiast. You've all eventually understood where we were with its potential as standing on the shore of an island years later after deepening his understanding of the agricultural manufacturing and medical components. He feels that we're standing on the shore of a continent. He contends that maybe the ancients knew something that we're now trying to discover. Again, Israel is in the process of medicalization, as you've all puts it, ensuring that each patient tizen indication or qualifying condition to his or her cannabis use. From there, the country has five bucks worth of information on how the program works, which you've all takes us through. Welcome to cannabis economy. I'm your host Seth Adler. Check us out on social with the handicap economy. That's students in the word economy. Uvar land shaft. So you valentia

Speaker 3: what kind of last name is lunch left. What does this view? It's the coming from the German ward. It's landscape. It's very pretty. It's very pretty because you know, Adler is a eagle, you know, that, that that's what that means. So we're both German kind of, but it is. We a multi, multi continents in nations, immigrants here in Israel and that's, we all come together. We come together in Israel. So how, you know, how do you come to cannabis, right? You have this, this long history, we're not going to get into it really, but essentially though you, you're running the cannabis in Israel, how, Eh, I became to be the director of the Imch, the Israeli medical cannabis agency in the beginning of 2013 and after Eh,

Speaker 3: a different career in different things and then up to date and I didn't knew much about cannabis and you know, that kind of be succeeds and you know, that kind of b so much. Why not or whatever you call it exists. But I didn't knew much about it. I knew it because we are, we have eyes, we have our noses, but I didn't understand much about it. But then I understood that we are really, really, really standing on the, on the, on the shore of some island now after three years in, after a really heavy duty drill down to each and every part of Sunday from the culture part, manufacturing parts to the kind of be going to be new age spots and the mechanism and the, the, the pharmacokinetics of the feet, Eh, for pharmacokinetics and all the, all the aspects of kind of basic and say that I think that it's not a show off an island.

Speaker 3: I think it's a show for continent that we're just discovering essentially. We're right in the beginning in some, in many ways maybe I will entrance fathers of the main kind knew something's now we trying to. We discover again. There we go. So, you know, I, I want to make sure that we touch a, exactly what you are doing with, uh, you know, um, with these five books that you have, right? Not only the five books. Yeah. The Israeli method is towards digitalization. I like to say, when you say medicalization, I say Hashtag medicalization. That's what I do. After you say that, you should know that. Okay, so that everybody can post a post about it on social. Yeah. Okay. Yeah, so medicalization, it's the use of cannabis for medical purposes, not legalization. It's medicalization medicalization. It'll be soon based on very, very simple outlines first that we must need medical indication for prescribing, kind of. We called them qualifying conditions. We're talking about PTSD, we're talking about a Ms. we're talking about Crohn's, talking about indications, right?

Speaker 3: Medical indications because we have to to to move and open the path. Opened the doors to treat kind of be like any other medicine, like any other medicine or drug, whatever name you call it, but medicine. Okay. And the, the other, the other basins is that after we will have our medical indication and we will have our eh medical, a clinical practice about cannabis, which is very, very not simple to have it, but after we will have it, we will have the medical indication and eh, Eh, the, the medical knowhow. Then we can train our medical staff, medical doctors, the MD to prescribe cannabis just like any other medicine. Right. But then the patients will go to the pharmacy to buy those kinds of products, kind of his medications, but in the pharmacy they should find a kind of these products and we mean medical grade cannot be spodak. Product's not going to be regular flowers that grows by some field or some grown and it's should be standard 10 should make standardization of medical cannabis products and the way that will make them available as generic products in the, with the constant and control controlled components inside. And we will know what we are giving outpatients. Everything should be very, very, very, very standardized and it's a way to do it. And then we can treat this like any other meds.

Speaker 1: When there's doubt, take the high road for more. Go to [inaudible] dot com slash Canada economy, vall land shaft, the director of the Israeli medical cannabis agency. You've all land chef joins us to take us through cannabis regulations in the Holy Land, not originally a cannabis enthusiast. You've all eventually understood where we were with its potential as standing on the shore of an island years later after deepening his understanding of the agricultural manufacturing and medical components. He feels that we're standing on the shore of a continent. He contends that maybe the ancients knew something that we're now trying to discover. Again, Israel is in the process of medicalization, as you've all puts it, ensuring that each patient tizen indication or qualifying condition to his or her cannabis use. From there, the country has five bucks worth of information on how the program works, which you've all takes us through. Welcome to cannabis economy. I'm your host Seth Adler. Check us out on social with the handicap economy. That's students in the word economy. Uvar land shaft. So you valentia

Speaker 3: what kind of last name is lunch left. What does this view? It's the coming from the German ward. It's landscape. It's very pretty. It's very pretty because you know, Adler is a eagle, you know, that, that that's what that means. So we're both German kind of, but it is. We a multi, multi continents in nations, immigrants here in Israel and that's, we all come together. We come together in Israel. So how, you know, how do you come to cannabis, right? You have this, this long history, we're not going to get into it really, but essentially though you, you're running the cannabis in Israel, how, Eh, I became to be the director of the Imch, the Israeli medical cannabis agency in the beginning of 2013 and after Eh,

Speaker 3: a different career in different things and then up to date and I didn't knew much about cannabis and you know, that kind of be succeeds and you know, that kind of b so much. Why not or whatever you call it exists. But I didn't knew much about it. I knew it because we are, we have eyes, we have our noses, but I didn't understand much about it. But then I understood that we are really, really, really standing on the, on the, on the shore of some island now after three years in, after a really heavy duty drill down to each and every part of Sunday from the culture part, manufacturing parts to the kind of be going to be new age spots and the mechanism and the, the, the pharmacokinetics of the feet, Eh, for pharmacokinetics and all the, all the aspects of kind of basic and say that I think that it's not a show off an island.

Speaker 3: I think it's a show for continent that we're just discovering essentially. We're right in the beginning in some, in many ways maybe I will entrance fathers of the main kind knew something's now we trying to. We discover again. There we go. So, you know, I, I want to make sure that we touch a, exactly what you are doing with, uh, you know, um, with these five books that you have, right? Not only the five books. Yeah. The Israeli method is towards digitalization. I like to say, when you say medicalization, I say Hashtag medicalization. That's what I do. After you say that, you should know that. Okay, so that everybody can post a post about it on social. Yeah. Okay. Yeah, so medicalization, it's the use of cannabis for medical purposes, not legalization. It's medicalization medicalization. It'll be soon based on very, very simple outlines first that we must need medical indication for prescribing, kind of. We called them qualifying conditions. We're talking about PTSD, we're talking about a Ms. we're talking about Crohn's, talking about indications, right?

Speaker 3: Medical indications because we have to to to move and open the path. Opened the doors to treat kind of be like any other medicine, like any other medicine or drug, whatever name you call it, but medicine. Okay. And the, the other, the other basins is that after we will have our medical indication and we will have our eh medical, a clinical practice about cannabis, which is very, very not simple to have it, but after we will have it, we will have the medical indication and eh, Eh, the, the medical knowhow. Then we can train our medical staff, medical doctors, the MD to prescribe cannabis just like any other medicine. Right. But then the patients will go to the pharmacy to buy those kinds of products, kind of his medications, but in the pharmacy they should find a kind of these products and we mean medical grade cannot be spodak. Product's not going to be regular flowers that grows by some field or some grown and it's should be standard 10 should make standardization of medical cannabis products and the way that will make them available as generic products in the, with the constant and control controlled components inside. And we will know what we are giving outpatients. Everything should be very, very, very, very standardized and it's a way to do it. And then we can treat this like any other meds.

Speaker 4: Uh, you, uh, have we have talked about how important the doctors are to this equation. You know, you're talking about basically the medical supply chain of getting a medicine from conception to, uh, to indication as far as the doctors are concerned, how important are they to the equation? How important are they to what you're doing and what you, you know, what you're doing to what they're doing so that everybody's on the same.

Speaker 3: The point, the point, the key for any medical, any medical treatment, we believe it should, should, should the path through. It's we should. We should have Dr. withers with Dr. shook should control the treatment. The doctor, the MDS. I mean like in any other medicine. It's not that the people who were sick, we go to some growers or to somewhere a agriculture company that knows maybe a lot about agricultural, but what they know about md. The doctors are the key, but in order to to, to, to gain the, the help full in there, the doctors to be with us and the doctoral very wisely said, okay, we know we learn in farm, in, in a, in a medical, in medical school. We're no allow. We learned abouT the other drugs. Are there other medicines but we never learned about cannabis please teachers and that was a really point that we didn't know since then how to deal with because no, not no way.

Speaker 3: No. Nobody in the world. His clinical guides know about cannabis. Not, not even the world. Nobody has the, the clinical practice how to to to meet the patient. What to what to examine, how to treat him with what kind of is with what strengths, with what potency of cannabinoids, how to begin with the sativa within endeca, how to combine together, what to give him inhaled cannabis or drops of cannabis or the digestive cannabis, how to treat it, how to, how to make out to, to go with him in the route of using cannabis, how to make the determination with, with uh, if something helps. Okay. I'll, if something held that doesn't tell you how to change it, how to change the amounts. So we'd say it's a, a multi, a multilayered, multilayered, faceted multi, multi, multi site. Everything clinical practice. Since then, nobody in the world has it.

Speaker 3: Everybody knew that we should find it. That we should maybe some days after a lot of clinical trials and so and after gaining a lot of other eh knowledge eventually will eventually it will happen. But nobody had it until about two months ago because now in Israel with the greatest assistance of officer and with the greatest assistant or the name of a professor or a known effect, which was the general manager, the general director of minister of ellis, now he's the deputy to general a manager and we did a lot of assistant professor, a professor, shapiro in a doctor door and dr and dr marino's and the professor obl, a lot of well known physician and far from a city and the people from the in a lot of others. We here in Israel, we, we, we have now that we call it the imc, gcp is known as the green book, the gcp.

Speaker 3: It's the good clinical practice. four doctors and about a month ago we began our, the training of our israeli doctors. Every trending is taking a month. It's, it's four a meetings for meetings. We make it every friday. That's why taking a month. So you started in the morning. If it's friday, right? Because you've got to be done early. We have to accept that to accept the shabbat day, late afternoon, the we are doing it, you know, the holy shabbat is give you a bless of the relaxed in the absorbing everything that you tasted during the week and this is like the, the last drop on the tastes that everybody hates. So they suggested the, the, the knowledge. Very, very good during the holy shabbat. But eh, we finished the first day course for doctors in the three weeks ago, finished the second course and we are now running the third course for doctors and like that we will run the false and the feast it courses that we have a enough doctors in Israel between 100 to 200 doctors that are qualified to prescribe cannot be seen. The medical grade, the sixth and the seventh, maybe the sixth, maybe the seventh course will be international groups because other countries approach us. They like to learn. They like to, to a asked to help them to, to teach their doctors. So we believe that the. Maybe in july or july or in august, we're going to run another course in international calls to train the trainers for other governments that like to come here. They come here

Speaker 4: and of course everybody has to come from in their life. Yeah, exactly. That's why I'm here. Right. Um, as far as the other countries are concerned, what are the, you know, they're coming to you for the knowledge and then what are you giving to them, you know, as far as, uh, as far as what you have established here.

Speaker 3: Okay. Because we didn't, we didn't the right. only these, the imc, gcp, the green book we wrote the whole, you know, in, in, in, in, in a, in medication, in regular drugs. The pharmacopeia, the pharmacopeia is them. The pharmacopoeia is the whole in the whole collection of formal documents and professional knowledge sources required to ensuring equality of, of, of, a, of standard, of practicing. So we call it the kind of compare the farmer, you know, the pharmacopeia is far more into drug and compare. It's to create this from ancient greek. But the, the, we call it the imc cornucopian, the ice capades total coalition of formal documents to really to ensure quality of medical grade cannabis. Medical cannabis is something that nobody still we think doesn't have it and they all kind of capella, we ensure that our, our patients and the patient that will go to the pharmacy with a prescription, that they get the prescription from the doctors that will find in the pharmacies kind of be in medical grade that was producing for full days and needs to make these chain.

Speaker 3: You must need first a gap, good agricultural practicing book that contains everything about how to grow to cultivate a cannabis for medical purposes in. What's the consensus of causeway? It's, it's a. We take a lot of parts of it. We take, we, we adapt some part of w, w, h a and galatians is about the plants, the plants, you'll regulation, but we also put a lot of a lot of israeli in the agriculture knowledge inside the about the cannabis because we area. We looked on knowledge. Then those are the kind of is that we cultivate will, will pass to the other chain which is the manufacturer manufacturer, right. And that's why we have the imc gmp, good manufacturing practices and these contents. Every practice about how to manufacture products have different effects for a product kind of be great products and then it's the other chances to gdp, good distribution practice, how to distribute it and of course the imc gcsp, good security practice because it's kind of base and we have to also to make some security because eh, eh, because we don't want these say cannabis lik to unauthorized persons to leak out to people who do not know how to make the benefit of medical medical benefit out of it.

Speaker 3: so if I have ptsd and then this gets out, you don't necessarily know exactly what, you know, a strain if it's a cd, but cbd rich or if it's the rich or maybe a hybrid, which best for me, if you have a patient, you're going to a doctor, what the doctor is examined, the ductile. Maybe it's examine neW somethings, maybe asked you things, but what do you write? What is prescribing you he prescribing, you kind of is. He doesn't know which kind of is how, what percentage of cbd to thc, if it's indigo, if it's a sativa, what to give you a drops or inhaled and or to combine with them or part of it like that. He should know it until now. There's no data or not, not so. Not that. Not not a clinical system or guidance to tell him hoW to do so how to go in this, eh, between these lines.

Speaker 3: So we take the. So what happens now, we take the prescription big sin prescription and you go to a pharmacy. It's not pharmacy today. You're going to a delivery. Oh yeah, I do. I shop for toys for dispensary shop and then the grower or people on his behalf advise you, but it's not the medical way is like any other medically medical, like you said, with a white jacket, right? White system and we are aiming and we're thinking that if we want to treat this like any other medicine, we should act and going in the same route. ThAt cannot be sweet, prescribed, prescribed to the patients by doctors that we work according to this and eh, eh, after, after we passed the training and the training the day they will, eh, the doctors will prescribe kind of bs to the patients. The patients will go to a pharmacy. They, it's the point that they will meet the medical grade kind of products.

Speaker 4: When we met in New York in 2014. Right now it's 2017 when we're talking now. And how much has your thinking evolved? Where were, what were you thinking then and what are you thinking now? How, how has it changed?

Speaker 3: Oh, okay. The question I told you before, and I'm trying now to out to our, to condense it first I have to thank you. Thank you. Because you explored in the convention that you make there. It was the con, the same cannabis economy economy summit that you invited me to, to, to open the. So it was the. Didn't know what the bottom line is that he's not the all in all the world, the facing the same problems. Challenges like we are in Israel and then the store, the second thing is that we, if we just put enough effort and enough mind and enough a willing in desire like in Israel, we know how to make it take in the other things in Israel we can achieve and we can get this breakthrough in order to, to, uh, to, to his medicalization because we understand that in cannabis, some something happened here in the 10 years from now we both going to sit, we're going to be a little bit older so we'll see it our own on the bench, you know, with the, with the, with the walker walker and they or in miami on the beach.

Speaker 3: And we will see that. And we. and we said you are a member 10 years ago or 17 years ago because the, your, your summit was three years ago. And you'll remember since then, a lot of people speak about a lot of people dream about going to bs. A lot of people, things that they want to get the knowhow but nobody really heavy. so we understand that we have to put a lot of effort. So first of all we, we, we, we, we, we spoke with professor, we told them our fee but for some shit on him. His name is mr lam. It's rough. In april we told him, professional, mature them. Come on, let's make it, let's make the dream come true. Right? Let's make the dream of making kind of be close as possible to any other medication. Let's make it known and the first step, but we should make.

Speaker 3: it's to make the, the good clinical practice in order to have the doctor with us because without the mds, with the doctors, it is not medical. Right. And the also the greater population. What do you think about carnaby's? Gonna be client. I was thinking I want to, I, I'm, I'm seeing my mother and my mother friends is begin. Okay. Kind of bs with the alpha for smile. Right? Right. It should not be. So there you go. Everybody should look. I believe they will look at and kind of be like any other medicine in the coming future. In order to that, we have to, we have to have the doctors with us and to have in order to have the doctor with us, we have, we must've, we must have the the, the clinical knowhow and to try to educate and train the doctors to teach them.

Speaker 3: They didn't learn in school or in school of medicine. They did not learn about cannabis, so we have to teach them in order to to to the day will be with us and these they will be with us or we will assist them. Sorry to treat their patients. Kind of. Bees can give a very good solution to their patients. There we go. Better late than never, right? Yeah. I don't. I don't think that now it's late. I believe that we are now standing on the shores of an island all the world now understand that Israel is the first one that's standing on the show of this island, of this medicalization island. I believe that we is the first commerce. We understand that it's not an island. It's a continent. It's a continent is an exciting, very big, very a challenging continent and the major benefit going to be for the patients. That's it. That's it. We're goiNg to solve people's problems. I doN't know if we are, but we're going to help them to, to, to, to get rid of a few.

Speaker 4: Okay. All right, so I've got three final questions. I'll tell you what they are and then I'll ask you them in order. what has most surprised you in cannabis? That's the first question. What has most surprised you in life? That's the second question, and then on the soundtrack of your life, one track, one song that's got to be on there, but first things first, what has most surprised you in cannabis?

Speaker 3: Most surprising in kind of is the big gap between what people think, feel, think that they know in between the lack of information or or in the or because the information was. I believe tHat it always there, but it needs a lot of effort just to try to collect it all together in order to make this building what we're calling the payer. You can be in the building out of five major stone or one stone, but can have it from a lot, a lot of little breaks, so we ever to put a lot, a lot of effort in to collect a lot, a lot of knowledge and sometimes when we didn't have to blow the knowledge, I tell you the truth bravely to get beat by a bridge by the power of attorney that we have is the regulators and the. It's not a simple answer. It's not the simple things to do. That's why we're all, all of our stuff's in committee with our doctors committee, with our indications committee, with the assistance of professor mature lemon oil, which help us to create this a cornucopia, which is the real bridge. We believe between cannabis as a

Speaker 4: as what it is, what it is a medical cannabis in two medical, a great of as far as building bridges. You also, the board of directors iNcludes essentially a number of essential components of the, of the government here and so can you just run through those. You said it's agriculture. You said it's customs, right? You know?

Speaker 3: Yeah. The board of directors of the amca, it's written in the israeli, these decision of the government, it's a contains the minister's treasury, the minister of finance, minister of culture, the minister ellis of course, and the deputy to general manager, a professor on a fake. He is the chief of the board of directors this way. He's my boss. Monastery of internal security and also the police of Israel and also the the customer authority and. Oh sorry. ANd also the ministry of judgment. So all of these are the parts of the, the board of directors also we have in the board of directors, the mca board of directors, we call it. I've been in the inter, eh, the multi, the government in history as a committee. We have also some, a in some people that we invite such as so mature law such as well known doctors that will assist us in the door. Of course that will help too. That can help us in several. But if we need needed to, to, to vote, the voting is according to who is a partner of the board of directors

Speaker 4: of the board. Alright. Alright. So that's cannabis. What has most surprised you in? I wonder if what? What? What would you. What will you say to this?

Speaker 3: Things that we do not know things to do. We do not know.

Speaker 3: A lot of times in life we see that we know things, we getting our stomach a stomach feelings and we think that we. Maybe we learn something, we use them from something, but the point is always to listen, always to find things that you do not know. And the point is, the real true answer is that we know everything about the babies. We know everything about how to make babies. We're enjoying. Make you sure of course, but everybody will say, did the first moment that he was stoned, it was the birth of his babies. He stood by his wife and see the birth of his babies. It's, it's a. It's a wonderful creation. It's the wonder of of, of what we are calling good and to meet god. Everybody meets god in everyday, but we'll do not observe that we're meeting good.

Speaker 4: This is. That's a big answer right there. Yeah, that's big. That's a big switch there. You go, all right, so, uh, this will be easier on the soundtrack of your life. One track, one song that's got to be on there. So yeah, this is a song that you like, that you know along the way is important, but then hebrew, whatever you want, you want me to sing to, you know, you can if you want, but I just want you to say what song it is so that we find out a little bit more about you, but if you'd like to sing, please do. Some people have.

Speaker 3: No, but I can, I can. I didn't think you Would. You will find the music by yourself. Okay. It's very, very easy. Yeah. It's really, it's a song that too. I know that not also me, but a lot of friends of mine, I believe the majority of the, the, the jewish, we sing it almost every friday in almost every morning and it's called hallelujah in the international world. Hallelujah. And it's come from the helium. It's, hallelujah. Hallelujah. Hallelujah. Bill kills a big vote of a little bit of good luck, a little bit thicker. Chauffeur, benevolent makino. Hallelujah. Hallelujah. Hallelujah. Hallelujah. Hallelujah. Hallelujah. And if you combine this words with the delay, the singer, the just the died some months ago, they're not going.

Speaker 4: Yeah. Oh sure. Leonard cohen, of course. Hallelujah. Yes,

Speaker 3: but it's a different world, but you can sing this world with the words of the other one. Yeah, with the, with their music and you know, sometimes you have to praise the gods. So we are all pressing it each and everyday, especially here in jerusalem. There you go. Okay. It's always good to see you too, bro.

Speaker 1: And there you have. You've all land shaft. That's good guy doing a big job. He really does feel that we are on the precipice of something huge, which of course if you're listening to this, you feel too. So thank you so much to uva for his time. Always great seeing him and thank you for listening.

Read the full transcript:

Become a member to access to webinars, quarterly reports, contributor columns, shows, excerpts, and complete podcast transcripts

Become a Member

Already a member? Login here.

Subscribe now to get every episode.

Cannabis Economy is a real-time history of legal cannabis. We chronicle how personal and industry histories have combined to provide our current reality.